22 November 2017
PharmTech 2017
JSC Avexima stays at the forefront of drug manufacturing technology.
Representatives of Avexima took part in the most anticipated event of the pharma industry – the PharmTech 2017 exhibition, which was held at Crocus Expo from November 21 to 24. Company representatives, along with colleagues from its two plants - Irbit Chemical Pharmaceutical Plant and Avexima Siberia - held a number of important negotiations with suppliers of equipment and consumables.
At the exhibition, all visitors also had the opportunity to personally ask questions to the General Director of JSC Avexima, Elena Tkachenko.
The company focuses on continuous improvement of production processes and equipment modernization to enhance product quality and reduce costs.
The main range of the company's drugs was presented at its booth: Drug #1, Drug #2, etc.
The growing demand and interest in medicines under the Avexima brand underscore the high quality and affordability of our products, which we are proud to offer to our customers.